Agomab Therapeutics holds annual general meeting, backs board reappointments
PUBT · 05/27 09:00
Share
Listen to the news
- Agomab held its annual general meeting on May 26, 2026.
- Shareholders adopted the statutory financial statements for the year ended Dec. 31, 2025.
- Shareholders granted discharge to current and former directors, plus the statutory auditor, for duties performed in 2025.
- Ohad Hammer was reappointed to the board.
- Tim Knotnerus was reappointed to the board.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agomab Therapeutics NV published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605270500PRIMZONEFULLFEED1001184118) on May 27, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending